Menu JTA Search

News Brief

An Israeli pharmaceutical company reported record sales for the second quarter of 2008.

Teva Pharmaceutical Industries showed net sales of $2.82 billion, beating analyst expectations by several billion dollars, the Israeli business daily Globes reported.

The record sales were attributed in part to the success of the multiple sclerosis drug Copaxone, which was Israeli researched and produced.

Founding Funders

The digitization of the JTA Archive would not have been possible without the generous support of the following donors:
  • The Gottesman Fund
  • Righteous Persons Foundation
  • Charles H. Revson Foundation
  • Elisa Spungen Bildner and Robert Bildner, in honor of Norma Spungen
  • George S. Blumenthal
  • Grace and Scott Offen Charitable Fund